|
|
|
|
|
Cancer Newsletter
|
|
|
|
Research News
|
Drugs used in cancer therapy increase toxicity of chemotherapy in mice. read more
A one-two punch hits pancreatic cancer where it hurts. read more
Biomarker could lead to personalized therapies for prostate cancer. read more
Deploying an ancient defense to kill cancer. read more
Inflammation: It takes two to tango. read more
Anti-cancer drug gets a boost when combined with antirheumatic. read more
Nanoparticle treatment could improve immunotherapy against cancer. read more
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
Now Live! Future Lab: Trends in Biopharmaceutical Analysis
|
|
Keep up with the latest trends in Biopharmaceutical Analysis. Learn how scientists are improving on tools and methodologies to identify novel biologics, monitor post-translational modifications, and create more effective biosimilars, biobetters and antibody-drug conjugates. read more
|
|
|
|
|
ATCC Breast Cancer Cell Panel. read more
Anti-FeLV / Feline Leukemia Virus Antibody (MaxLight 405). read more
|
|
|
|
|
|
|
Event
|
|
Pain Therapeutics 2017
|
|
Created with an expert scientific advisory board, SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.... read more
|
|
|
4th Peptides Event
|
|
SMi Group's 4th Peptides Conference will return to London on 6 & 7 July at the Holiday Inn Kensington Forum. Featuring 19 presentations, 2 exclusive workshops, and a new lineup of expert speakers, the 2017 agenda will provide you two days of invaluable knowledge and networking opportunities.
In the... read more
|
|
|
More Events »
|
|
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA
|
|
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings or
Unsubscribe
|
|
